The taste and texture of meat and dairy analogues have come a long way. But according to alternative protein experts, ‘there is still room for improvement’. How will the next generation of innovators win over consumers, and what hurdles will they need...
As Belgian startup Paleo ups the ante in the meat alternatives space with a suite of meaty-tasting heme proteins from multiple animal species it aims to commercialize in 2023, FoodNavigator-USA caught up with CEO Hermes Sanctorum to talk mammoth myoglobin,...
Boston-based foodtech firm Motif FoodWorks – which has raised $345m since spinning off from synthetic biology firm Ginkgo BioWorks in February 2019 – has just engaged in a round of layoffs, FoodNavigator-USA understands.
Motif FoodWorks has filed a motion to stay a patent infringement lawsuit brought by Impossible Foods over the use of heme ingredients in meat alternatives while the US Patent Trial and Appeal Board (PTAB) reviews the patent at the heart of the case.
Motif FoodWorks has upped the ante in a high-stakes legal dispute with plant-based meat co Impossible Foods over meaty-tasting ‘heme’ ingredients by filing a petition with the Patent Trial and Appeal Board to challenge the validity of a patent it argues...
Boston-based Motif FoodWorks says it is “very confident” it will prevail in its legal spat with Impossible Foods over a new generation of ‘meaty’ flavors produced by precision fermentation.
Two more high-profile players in the alt meat space are clashing over IP, with Impossible Foods accusing Motif FoodWorks of infringing a patent it secured in 2020 covering the use of its flagship ‘heme’ ingredient in meat substitutes.
HEMAMI – a much-anticipated meaty flavor Motif FoodWorks reckons could be a game changer in the meat alternatives arena by delivering the flavor and aroma of the real thing - is now commercially available for large-scale distribution to customers.
Motif FoodWorks has submitted a GRAS notification for myoglobin, a heme-binding protein found in the muscle tissue of cows that Motif is expressing in a genetically engineered yeast strain. The protein – which the Boston-based firm reckons could be a...